[144] ORACLE CORP SEC Filing
Rhea-AI Filing Summary
ORCL common stock holder filed a notice to sell 10,000 shares through Fidelity Brokerage Services LLC on or after December 19, 2025, with an aggregate market value of 1,925,152.18. These shares were acquired on September 20, 2025 via restricted stock vesting from the issuer as compensation.
Over the prior three months, the same seller, Clayton Magouyrk, sold 40,000 common shares on October 21, 2025 for gross proceeds of 11,065,506.10. The issuer reported 2,873,130,000 common shares outstanding, and the securities are listed on the NYSE.
Positive
- None.
Negative
- None.
FAQ
How many ORCL common shares are planned for sale in this Form 144?
The notice covers the planned sale of 10,000 shares of ORCL common stock, to be sold through Fidelity Brokerage Services LLC on or about December 19, 2025.
What is the aggregate market value of the ORCL shares to be sold?
The 10,000 ORCL common shares planned for sale have an aggregate market value of 1,925,152.18 according to the disclosure.
How and when were the ORCL shares in this Form 144 acquired?
The 10,000 ORCL common shares were acquired on September 20, 2025 via restricted stock vesting from the issuer, described as compensation.
What ORCL stock sales has the filer made in the last three months?
During the prior three months, Clayton Magouyrk sold 40,000 ORCL common shares on October 21, 2025, generating gross proceeds of 11,065,506.10.
How many ORCL common shares are outstanding according to this notice?
The disclosure states that the issuer has 2,873,130,000 ORCL common shares outstanding.
On which exchange are the ORCL shares in this Form 144 listed?
The common shares referenced in this notice are listed on the NYSE.
What representation does the seller make about information on the issuer?
By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.